Compound | Cytotoxicity LC50[μM] | Proliferation IC50[μM] | GAG synthesis [%] |
---|
IFG-001 | 13.9 | - | 120 ± 56 |
IFG-018 | 41.7 | - | 76 ± 38 |
IFG-021 | 11.0 | - | 75 ± 25 |
IFG-027 | 13.1 | - | 69 ± 46 |
IFG-032 | n/c | 17.4 | 57 ± 24 |
IFG-034 | n/c | 22.9 | 65 ± 19 |
IFG-035 | 22.6 | - | 93 ± 70 |
IFG-036 | n/c | 11.2 | 64 ± 21 |
IFG-037 | 23.5 | - | 88 ± 84 |
IFG-038 | n/c | 19.9 | 55 ± 13 |
IFG-042 | 22.0 | - | 48 ± 29 |
IFG-043 | 14.5 | - | 46 ± 41 |
IFG-046 | 20.7 | - | 118 ± 72 |
IFG-048 | 20.3 | - | 73 ± 5 |
IFG-050 | 11.6 | - | 100 ± 65 |
IFG-051 | 14.6 | - | 127 ± 109 |
IFG-052 | 15.8 | - | 74 ± 19 |
IFG-053 | n/c | 53.0 | 92 ± 52 |
IFG-054 | n/c | n/a | 119 ± 64 |
IFG-060 | 14.9 | - | 31 ± 8 |
IFG-061 | 18.8 | - | 50 ± 25 |
IFG-062 | 12.1 | - | 403 ± 206 |
IFG-063 | 51.5 | - | 76 ± 6 |
IFG-064 | 6.6 | - | 133 ± 77 |
IFG-065 | 22.7 | - | 96 ± 22 |
IFG-066 | n/c | 14.6 | 34 ± 10 |
IFG-067 | 15.1 | - | 96 ± 38 |
IFG-070 | n/c | 48.1 | 101 ± 30 |
IFG-071 | n/c | 17.9 | 49 ± 20 |
IFG-072 | n/c | 14.1 | 79 ± 42 |
IFG-073 | 27.5 | - | 83 ± 32 |
IFG-074 | 44.1 | - | 88 ± 39 |
Genistein | n/c | 16.9 | 55 ± 31 |
- Cytotoxicity is expressed as LC50 index value, i.e. concentration of the tested drug [μM] that is lethal to 50% of cells in a culture exposed to the tested compound for 24 hours. Antiproliferative activity is expressed as IC50 index value, i.e. concentration of the tested drug [μM] that causes 50% inhibition of cell proliferation in a culture exposed to the tested compound for 7 days. Kinetics of GAG synthesis is expressed as relative 35 S incorporation into GAGs after 3-day exposure to derivatives of genistein at 30 μM concentration. Labeling was conducted for 24 hours with 20 μCi/ml H2[35 S]O4. Radioactivity of incorporated 35 S was measured in a scintillation counter, calculated per DNA amount [dpm/ng DNA] and expressed as the percentage of control, where 100% corresponds to the relative 35 S incorporation into control (cell culture treated with 0.05% dimethylformamide).
- n/c denotes experiments in which no cytotoxicity was observed (over 90% of cells survived at concentrations ranging from 1 to 30 μM).
- n/a denotes experiments in which no antiproliferative activity was observed (relative proliferation was over 95% at concentrations ranging from 1 to 30 μM).
- - denotes experiments in which IC50 for antiproliferative activities could not be determined due to cytotoxic effects of the tested compounds.